Tumor markers also decreased markedly one month after treatment (CEA, 10.79 ng/mL; CA125, 10.81 U/mL; CYFRA21-1, 2.6 ng/mL) (Figure 2A). This evidence concerns the gene CEACAM5 and neoplasm.